ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 232 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,129,200 | -78.2% | 60,000 | -81.5% | 0.26% | -79.5% |
| Q4 2022 | $5,174,001 | -2.7% | 325,000 | 0.0% | 1.25% | +17.7% |
| Q3 2022 | $5,317,000 | +11458.7% | 325,000 | +17168.9% | 1.06% | +17566.7% |
| Q1 2022 | $46,000 | +9.5% | 1,882 | +6.6% | 0.01% | 0.0% |
| Q4 2021 | $42,000 | -99.1% | 1,765 | -99.4% | 0.01% | -98.2% |
| Q3 2021 | $4,681,000 | -8.6% | 281,765 | +34.3% | 0.33% | -20.3% |
| Q2 2021 | $5,119,000 | -66.0% | 209,866 | -64.1% | 0.41% | -18.3% |
| Q1 2021 | $15,076,000 | +403.4% | 584,308 | +943.3% | 0.51% | +284.1% |
| Q4 2020 | $2,995,000 | -53.5% | 56,008 | -64.1% | 0.13% | -71.7% |
| Q3 2020 | $6,436,000 | -46.0% | 156,008 | -36.6% | 0.47% | -50.8% |
| Q2 2020 | $11,924,000 | -27.6% | 246,008 | -36.9% | 0.95% | -23.5% |
| Q1 2020 | $16,478,000 | +175.1% | 390,000 | +178.6% | 1.24% | +27.8% |
| Q4 2019 | $5,989,000 | – | 140,000 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |